Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WL5F
|
|||
| Former ID |
DIB004632
|
|||
| Drug Name |
Grazax
|
|||
| Synonyms |
Alutard SQ; MK-7243; SCH-697243; Grass pollen allergy desensitization tablet, ALK-Abello; Biological grass pollen allergen (sublingual, Zydis), ALK-Abello; Grass pollen allergy desensitization tablet, ALK-Abello/Schering-Plough; Immunotherapy (grass pollen), ALK-Abello/Schering-Plough; Biological grass pollen allergen (sublingual, Zydis), ALK-Abello/Schering-Plough; Sublingual tablet-based immunotherapy (grass pollen allergies), Schering-Plough/ALK-Abello
Click to Show/Hide
|
|||
| Indication | Allergic rhinitis [ICD-11: CA08.0] | Approved | [1], [2] | |
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT02256553) Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (MK-3641-006). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.